Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors
申请人:Anderson R. David
公开号:US20050137220A1
公开(公告)日:2005-06-23
A method is described for inhibiting mitogen activated protein kinase-activated protein kinase-2 in a subject in need of such inhibition, where the method involves administering to the subject a beta-carboline MK-2 inhibiting compound, or a pharmaceutically acceptable salt thereof.
HUDLICKY T.; KUTCHAN T. M.; SHEN G.; SUTLIFF V. E.; COSCIA C. J., J. ORG. CHEM., 1981, 46, NO 8, 1738-1741
作者:HUDLICKY T.、 KUTCHAN T. M.、 SHEN G.、 SUTLIFF V. E.、 COSCIA C. J.
DOI:——
日期:——
[EN] BETA-CARBOLINE COMPOUNDS AND ANALOGUES THEREOF AND THEIR USE AS MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE-2 INHIBITORS<br/>[FR] COMPOSES DE BETA-CARBOLINE AINSI QUE LEURS ANALOGUES ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE PROTEINE KINASE-2 ACTIVEE PAR PROTEINE KINASE ACTIVEE PAR DES MITOGENES
申请人:PHARMACIA CORP
公开号:WO2005009370A2
公开(公告)日:2005-02-03
Novel methods and compositions are described for inhibiting mitogen activated protein kinase-activated protein kinase-2 in a subject. The method involves administering to the subject a beta-carboline MK-2 inhibiting compound, or a pharmaceutically acceptable salt, or isomer thereof. The novel compositions are capable of inhibiting mitogen activated protein kinase-activated protein kinase-2 and analogues thereof. Pharmaceutical compositions and kits that include these compounds are also described.
Improved synthesis and characterization of Pictet-Spengler adducts of phenylpyruvic acid and biogenic amines
作者:Tomas Hudlicky、Toni M. Kutchan、Grace Shen、Vincent E. Sutliff、Carmine J. Coscia